Senate approves new FDA chief
- Share via
From Times Wire Reports
The Senate voted 80 to 11 to confirm Andrew C. von Eschenbach to head the Food and Drug Administration, but only after breaking a filibuster in which he was accused of impeding congressional investigations.
Von Eschenbach, a former head of the National Cancer Institute, has been acting head of the FDA for more than year.
His predecessor, Lester M. Crawford, pleaded guilty in October to conflict of interest and false reporting of information about stocks he owned in food, beverage and medical device companies he was in charge of regulating.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
